VOLIBRIS

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug VOLIBRIS contains one active pharmaceutical ingredient (API):

1 Ambrisentan UNII HW6NV07QEC - AMBRISENTAN

Ambrisentan is an orally active, propanoic acid-class, ERA selective for the endothelin A (ETA) receptor. Endothelin plays a significant role in the pathophysiology of PAH. Read about Ambrisentan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VOLIBRIS Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02KX02	Ambrisentan	C Cardiovascular system → C02 Antihypertensives → C02K Other antihypertensives → C02KX Antihypertensives for pulmonary arterial hypertension
Discover more medicines within C02KX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12180C, 12186J, 12201E, 12212R, 5607D, 5608E, 9648T, 9649W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510612201111211, 510612202118211
Country: CA	Health Products and Food Branch	Identifier(s): 02307065, 02307073
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00886110, 01467220
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 357-MEE-0614
Country: EE	Ravimiamet	Identifier(s): 1349849, 1349850, 1349861, 1349872, 1863323, 1863334
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08451002, 08451004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 119984, 120007
Country: FR	Base de données publique des médicaments	Identifier(s): 66848183, 68499606
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 137558, 137563
Country: HK	Department of Health Drug Office	Identifier(s): 63502, 63503
Country: IE	Health Products Regulatory Authority	Identifier(s): 88517, 88518
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6242, 6243
Country: IT	Agenzia del Farmaco	Identifier(s): 038528028, 038528042
Country: JP	医薬品医療機器総合機構	Identifier(s): 2190031F1023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1032115, 1032116, 1032117, 1032118, 1093376
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 86797, 86800
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13875, 13876
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100192433, 100192456, 100461500
Country: SG	Health Sciences Authority	Identifier(s): 15093P, 15094P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522091133, 8699522091164, 8699522091171, 8699522091263
Country: ZA	Health Products Regulatory Authority	Identifier(s): 45/7.1.3/0106, 45/7.1.3/0107